Open AccessP035 Ozanimod for Moderate-to-Severe Ulcerative Colitis: North American Population Results During Induction and Maintenance in the Phase 3 True North Study
Author(s) -
David Hudesman,
Long Millie,
W Douglas,
Stephen B. Hanauer,
Subrata Ghosh,
AnnKatrin Petersen,
Marc Pondel,
Marjorie A. Silver,
Cross Raymond,
B G Feagan
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000798740.67469.6e
Subject(s) - medicine , population , clinical endpoint , placebo , ulcerative colitis , clinical trial , surgery , pathology , disease , alternative medicine , environmental health